Bone regeneration using beta-tricalcium phosphate in a calcium sulfate matrix

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Bone regeneration is crucial for treating bone defects.
• Beta-tricalcium phosphate (beta-TCP) is a commonly used bone graft material.
• Optimizing osteogenic potential of bone graft substitutes is an ongoing research area.

Purpose of the Study:

• To histomorphometrically compare the osteogenic potential of beta-tricalcium phosphate (beta-TCP) alone versus beta-TCP in a calcium sulfate (CS) matrix.
• To evaluate the efficacy of beta-TCP/CS composite in promoting bone regeneration in critical-sized defects.
• To assess the impact of graft materials on bone dimension preservation.

Main Methods:

• Four dogs underwent surgical creation of three 10 mm diameter x 5 mm depth defects in each iliac crest.
• Defects were grafted with beta-TCP/CS (Group A), beta-TCP alone (Group B), or left ungrafted (Group C).
• Histologic and morphometric analysis of undecalcified slides was performed after 4 months of healing without barrier membranes.

Main Results:

• Group A (beta-TCP/CS) showed complete bone formation, graft particle presence, and cortical bone restoration.
• Group B (beta-TCP) exhibited partial new bone fill with graft particles dominating and incomplete cortical restoration.
• Ungrafted sites (Group C) demonstrated incomplete new bone formation and limited cortical layer restoration.
• Mean new bone regeneration was significantly higher in Group A (49.38%) than Group B (40.31%) (P = .004).

Conclusions:

• The combination of beta-TCP with a CS matrix significantly enhances new bone regeneration compared to beta-TCP alone.
• Beta-TCP/CS composite effectively promotes vital bone fill and preserves bone dimensions in critical-sized defects.
• Calcium sulfate matrix enhances the osteogenic potential of beta-TCP for bone defect repair.